Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 23, Pages -Publisher
MDPI
DOI: 10.3390/jcm11237040
Keywords
Helicobacter infection; tetracycline; eradication; penicillin allergy; furazolidone; metronidazole; amoxicillin
Categories
Funding
- Medical and Health Science and Technology Project of Zhejiang Province
- [2020RC064]
Ask authors/readers for more resources
This review provides an update on tetracycline-containing bismuth quadruple eradication therapy for H. pylori infection, reviewing the efficacy and safety of the regimens, aiming to provide guidance for clinical practice.
Helicobacter pylori (HP) infection is closely associated with the development of chronic gastritis, peptic ulcer, and gastric cancer. However, the resistance rate of H. pylori strains to antibiotics such as clarithromycin, metronidazole, and levofloxacin has increased significantly, resulting in a significant decrease in the eradication efficacy of commonly used regimens. Tetracycline has received the attention of domestic and foreign scholars because of its low resistance. The purpose of this review is to provide an update on the tetracycline-containing bismuth quadruple eradication therapy for H. pylori infection and review the efficacy and safety of the regimens, hoping to provide guidance for clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available